Enter Gregory House, the misanthropic, diagnostic genius and protagonist of House, the hit TV medical drama. In House's cynical worldview everyone lies. And so when the baseball player says he's never used steroids, House doesn't believe him and treats his hypogonadism with Lupron.
Lupron?Even for House, who is renowned for prescribing drugs that will as easily kill the patient as save him, this treatment choice seems puzzling.
Dr. House's Lupron treatment also raised the eyebrows of Dominick Frosch and Sony Ta, UCLA medical researchers and authors of "Pharmaceutical Product Placement: Simply Script or Prescription for Trouble?" published last May in the Journal of Public Policy & Marketing (see accompanying article in this issue).
Frosch and Ta found the use of Lupron (leuprolide, from Abbott) and the four mentions of the drug on the show "suspicious," and wondered if they weren't a paid product placement (also called stealth or subliminal advertising)—the insertion of a product or service into a script or scene of a TV show, usually for a price negotiated with the network, producer, or scriptwriter.
PROMOTION OR PART OF THE STORY?
House (played by British actor Hugh Laurie) bears more than a little resemblance to Sherlock Holmes. Both are unconventional, both are drug addicts (Holmes to cocaine, House to Vicodin), and both are driven by unconventional means to solve cases: For Holmes, it's about catching a criminal; for House, it's about diagnosing a disease.
Each episode of House follows basically the same pattern: A patient is rushed to the hospital; House takes on the case; his team misdiagnoses the disease; the patient almost dies; a light bulb goes off in House's mind; he figures out the problem and the patient lives (usually). The disease is almost always arcane. In the case of the baseball player, it turns out to be colchicine poisoning. (Don't ask.)
The character of House, with his risky, high-prescribing habits, makes the show fertile ground for all kinds of drug mentions—more so perhaps than any other medical TV show. Overall, drug mentions have doubled on TV in the last two years, according to Nielsen Product Placement.
So what gives? Was the use of Lupron on House a product placement for promotional purposes?
"Absolutely not," says Harley Liker, medical adviser to House. The show, he says, which attracts 20 million viewers weekly, contains no paid pharmaceutical product placements.
"Zero, zero, none," says Liker. "I talked about this with the writers. Their reaction was that it was almost the opposite: They try to avoid mentioning specific brand names whenever possible, partly because of potential legal issues."
Liker, who holds both medical and business degrees and serves on a global advisory board for AstraZeneca, functions as a consultant on House. "I'm not on the set every day. I get a script, or I talk about an idea with someone. I make sure that the vernacular is appropriate and that the story line makes sense."
Lupron was not his idea. "It was not my detailing," says Liker. "Many people come up with ideas, including a doctor who is a full-time writer on the show."
Liker attributes House's off-label use of Lupron on the show more to House's character than the drug.
"House is very untraditional. He is a risk-taker, constantly thinking outside the box. He is actually more likely to use a drug off label than he is on-label. It has more to do with who Doctor House is and the way he approaches medicine."